ProFund Advisors »

Crispr Therapeutics shares owned by ProFund Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by ProFund Advisors from 13F filings

Historical chart of ProFund Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by ProFund Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.3M 29k 45.39
2023-06-30 $1.4M 24k 56.14
2023-03-31 $1.3M 29k 45.23
2022-12-31 $355k 8.7k 40.65
2022-09-30 $556k 8.5k 65.37
2022-06-30 $495k 8.1k 60.80
2022-03-31 $551k 8.8k 62.82